Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Spasticity of stroke patient, a very common complication in clinical practice, affects performance of hand function and gait pattern. It also interferes with quality of life of patients severely. Currently first line clinical approach to spasticity consist of physical therapy and pharmacological management. However, there are still some refractory cases that needed local intervention such as Botox injection.
So far, we only can use subjective methods to measure muscle tension, such as modified Ashworth scale and Tone Assessment Scale. In our previous study, we found that ultrasound shear wave image could correlate with muscle stiffness caused by poststroke spasticity. With this new method, we aim to establish a more objective method in measuring abnormal poststroke muscle tension before and after treatments and further monitor therapeutic effect. We also include several assessment scales to evaluate the correlation between measured muscle spasm and activity of daily living.
We hypothesize that the rheological changes in muscles muscle spasm after Botox injection can be detected by ultrasound shear wave image. Therapeutic effect can also be seen in its effect on daily functions.
In this project, we will use shear wave imaging of ultrasound to investigate the elasticity (and hardness) of the biceps brachii and brachialis muscle in stroke patients with unilateral hemiplegia before and after Botox injection. The findings of this project will provide the objective evaluation of muscle spasticity and its correlation with functional status, which will provide new points of view toward treatment of spasticity.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | The stroke patients who receive botulinum toxin injection at affected brachialis and/or biceps brachials. |
| |
| Control | The stroke patients who do not receive botulinum toxin injection at affected brachialis and/or biceps brachials in the past 3 months. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Botulinum toxin injection | Drug | Botulinum toxin injection at affected brachialis and/or biceps brachials. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Shear Wave Ultrasound Elastography | Shear wave ultrasound elastography measurement of spastic upper limb muscles, including biceps brachii and brachialis | During each follow up visit within 12 weeks time frame |
| Measure | Description | Time Frame |
|---|---|---|
| Barthel Index (Wade's version) | Barthel Index assessing activities of daily livings | During each follow up visit within 12 weeks time frame |
| Revised Nottingham Extended Activities of Daily Livings Scale |
Not provided
Inclusion Criteria:
[Intervention group]
[Control group]
Exclusion Criteria:
Not provided
Not provided
Not provided
Stroke patient aged above 20 years old with unilateral involvement.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Huey-Wen Liang, MD PHD | Contact | 886-2-23123456 | 66697 | ntuhpmr.4124@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Huey-Wen Liang, MD PHD | National Taiwan University Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Taiwan University Hospital | Taipei | 100 | Taiwan |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D009128 | Muscle Spasticity |
| D001906 | Botulism |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001905 | Botulinum Toxins |
| ID | Term |
|---|---|
| D008666 | Metalloendopeptidases |
| D010450 | Endopeptidases |
| D010447 | Peptide Hydrolases |
| D006867 | Hydrolases |
Not provided
Not provided
Not provided
Not provided
Not provided
Revised Nottingham Extended Scale assessing activities of daily livings
| During each follow up visit within 12 weeks time frame |
| Stroke Rehabilitation Assessment of Movement (STREAM), brief version | STREAM assessing movement condition | During each follow up visit within 12 weeks time frame |
| Modified Ashworth Scale (MAS) | MAS scale for assessing spasticity | During each follow up visit within 12 weeks time frame |
| Tone Assessment Scale (TAS) | TAS scale for assessing spasticity | During each follow up visit within 12 weeks time frame |
| Global improvement scale | Global improvement scale for assessing symptoms related to stroke | During each follow up visit within 12 weeks time frame |
| Self-report spasticity symptoms | Self-report spasticity symptoms for assessing spasticity | During each follow up visit within 12 weeks time frame |
| EuroQol | EuroQol for evaluating quality of life | During each follow up visit within 12 weeks time frame |
| Extended Activities of Daily Living | Extended Activities of Daily Living scale for evaluating activity of daily living | During each follow up visit within 12 weeks time frame |
| Postural Assessment Scale for Stroke Patients (PASS), brief version | PASS for evaluating symptoms related to stroke | During each follow up visit within 12 weeks time frame |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D009122 | Muscle Hypertonia |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D003015 | Clostridium Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D020511 | Neuromuscular Junction Diseases |
| D009468 | Neuromuscular Diseases |
| D020258 | Neurotoxicity Syndromes |
| D005517 | Foodborne Diseases |
| D011041 | Poisoning |
| D064419 | Chemically-Induced Disorders |
| D004798 |
| Enzymes |
| D045762 | Enzymes and Coenzymes |
| D045726 | Metalloproteases |
| D001426 | Bacterial Proteins |
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
| D001427 | Bacterial Toxins |
| D014118 | Toxins, Biological |
| D001685 | Biological Factors |